Causal associations between human plasma proteins and prostate cancer identified by proteome-wide Mendelian randomization
eLife · 2025
DOI: 10.7554/elife.101584 ↗Kurz gefasst
Metaanalyse in der Zeitschrift eLife, 2025. Verfasst von Lin Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Mendelian Randomization Analysis, Blood Proteins, Proteome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Prostate cancer (PCa) diagnosis is hampered by the limited specificity of current methods, necessitating more reliable biomarkers. To identify causal protein biomarkers and therapeutic targets in humans, we conducted a proteome-wide Mendelian randomization (MR) study. We first performed a meta-analysis of two independent genome-wide association studies, including 94,397 individuals with PCa and 192,372 controls, which identified five possible susceptibility loci (JAZF1, PDILM5, WDPCP, EEFSEC, TNS3) for PCa. Subsequently, MR and colocalization analyses were performed using genetic instruments for 4907 plasma proteins from deCODE Genetics (N=35,559) and 2940 plasma proteins from UK Biobank Pharma Proteomics Project (UKB-PPP) (N=54,219). Among 3722 human proteins analyzed, 193 were associated with PCa risk, with 20 high-risk proteins (including KLK3) validated across both cohorts. Functional annotation implicated immune and inflammatory responses and cell–cell interaction pathways. Druggability analyses nominated several potential drug targets for PCa, such as HSPB1, RRM2B, and PSCA. Our findings reveal novel risk loci and candidate protein biomarkers, providing new etiological insights and potential avenues for PCa early detection and therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Peking University First Hospital, Beijing, China.
- School of Pharmaceutical Sciences, Peking University, Beijing, China.
- Department of Urology, Peking University First Hospital, Beijing, China.
ORCID-Profile: Zhuona Rong, Xiaocong Pang
Förderung
- Beijing Municipal Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Chen, L., Gu, Y., Chen, Y., Yu, W., Zhou, Y., Rong, Z., & Pang, X. (2025). Causal associations between human plasma proteins and prostate cancer identified by proteome-wide Mendelian randomization. eLife. https://doi.org/10.7554/elife.101584
Vancouver
Chen L, Gu Y, Chen Y, Yu W, Zhou Y, Rong Z, et al. Causal associations between human plasma proteins and prostate cancer identified by proteome-wide Mendelian randomization. eLife. 2025. doi:10.7554/elife.101584
BibTeX
@article{Chen2025,
author = {Chen, Lin and Gu, Yanlun and Chen, Yuke and Yu, Wei and Zhou, Ying and Rong, Zhuona and Pang, Xiaocong},
title = {Causal associations between human plasma proteins and prostate cancer identified by proteome-wide Mendelian randomization},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.101584}
}
EUVIMED